We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+16.76%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$25.6B
AUM Growth
+$2.65B
(+12%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-4.57%
Top 10 Holdings %
Top 10 Hldgs %
14.38%
Holding
1,445
New
151
Increased
481
Reduced
509
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$56.6M |
| 2 |
Fidelity National Information Services
FIS
|
+$53M |
| 3 |
Advanced Micro Devices
AMD
|
+$48.1M |
| 4 |
RTX Corp
RTX
|
+$43.3M |
| 5 |
Analog Devices
ADI
|
+$38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$72.1M |
| 2 |
PepsiCo
PEP
|
+$70.8M |
| 3 |
American Express
AXP
|
+$70.7M |
| 4 |
Automatic Data Processing
ADP
|
+$49.7M |
| 5 |
Synchrony
SYF
|
+$47.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.67% |
| 2 | Healthcare | 15.33% |
| 3 | Consumer Discretionary | 10% |
| 4 | Financials | 9.76% |
| 5 | Industrials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Brinker International
EAT
$8.5B
| $7.13M | 0.03% |
160,660
-5,000
| -3% | -$225K |
|
527
Minerals Technologies
MTX
$2.11B
| $6.98M | 0.03% |
118,800
+26,800
| +29% | +$1.53M |
|
528
Southern Company
SO
$98.9B
| $6.98M | 0.03% |
135,030
-6,883
| -5% | -$337K |
|
|
CBLK
529
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $6.97M | 0.03% |
+500,000
| New | +$7.13M |
|
530
Euronet Worldwide
EEFT
$2.62B
| $6.97M | 0.03% |
+48,900
| New | +$6.1M |
|
531
Deluxe
DLX
$1.08B
| $6.96M | 0.03% |
159,100
+5,200
| +3% | +$233K |
|
532
Essent Group
ESNT
$6.13B
| $6.95M | 0.03% |
160,000
+7,300
| +5% | +$301K |
|
533
iShares MSCI Japan ETF
EWJ
$23.3B
| $6.95M | 0.03% |
126,970
+5,500
| +5% | +$296K |
|
|
COUP
534
DELISTED
Coupa Software Incorporated
COUP
| $6.94M | 0.03% |
76,317
-7,300
| -9% | -$626K |
|
535
Mid-America Apartment Communities
MAA
$14.4B
| $6.93M | 0.03% |
63,373
+19,766
| +45% | +$2.03M |
|
|
VMRK
536
Vivmark Residential
VMRK
$50.8B
| $6.92M | 0.03% |
91,900
+973
| +1% | +$70.1K |
|
537
Icon
ICLR
$13.3B
| $6.9M | 0.03% |
50,526
+8,117
| +19% | +$1.11M |
|
538
Halozyme
HALO
$12.1B
| $6.89M | 0.03% |
428,217
| – | – |
|
539
Aramark
ARMK
$15.4B
| $6.88M | 0.03% |
322,428
+188,303
| +140% | +$4.22M |
|
540
NETSCOUT
NTCT
$2.79B
| $6.82M | 0.03% |
243,100
+76,400
| +46% | +$2.03M |
|
541
Copart
CPRT
$28.7B
| $6.81M | 0.03% |
449,600
+51,744
| +13% | +$703K |
|
542
Hormel Foods
HRL
$11.4B
| $6.74M | 0.03% |
150,500
-6,327
| -4% | -$271K |
|
|
DHC
543
Diversified Healthcare Trust
DHC
$1.89B
| $6.69M | 0.03% |
567,768
+32,100
| +6% | +$411K |
|
544
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $6.68M | 0.03% |
157,200
| – | – |
|
|
HZNP
545
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $6.62M | 0.03% |
+250,510
| New | +$5.94M |
|
|
ARRY
546
DELISTED
Array Biopharma Inc
ARRY
| $6.56M | 0.03% |
269,252
-192,234
| -42% | -$4M |
|
547
iShares Russell Mid-Cap Growth ETF
IWP
$19B
| $6.53M | 0.03% |
96,308
+14,000
| +17% | +$899K |
|
548
AnaptysBio
ANAB
$1.62B
| $6.53M | 0.03% |
89,412
+10,004
| +13% | +$691K |
|
549
CoreCivic
CXW
$3.5B
| $6.5M | 0.03% |
334,000
+22,300
| +7% | +$440K |
|
|
CSGS
550
DELISTED
CSG Systems International
CSGS
| $6.49M | 0.03% |
153,500
-5,700
| -4% | -$220K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2019 Portfolio in Review
As of Q1 2019, Axa held 1,445 positions worth $25.6B, up 12% from $22.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa withdrew a net $1.17B in Q1 2019, closing 137 positions and reducing 509 holdings. Its most notable exit was Newfield Exploration, an estimated $15.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Axa opened a new position in BlackBerry worth $40.1M.
- Axa's largest Q1 2019 buy was BlackBerry: 3,971,844 shares worth $40.1M.
- Axa added most to Gilead Sciences in Q1 2019, an estimated $56.6M increase.
- Axa's biggest Q1 2019 reduction was Humana, cutting an estimated $72.1M.
- Axa fully exited Newfield Exploration in Q1 2019, selling an estimated $15.3M.
- Axa's ten largest holdings make up 14% of its $25.6B portfolio in Q1 2019.
- Axa opened 151 new positions and closed 137 in Q1 2019.
- Axa's portfolio value rose 12% quarter-over-quarter to $25.6B.
Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.